Rare diseases
Investigational molecules
Locations
Back to Austria55 clinical trials in Feldkirch, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
AustriaStudy on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer
AustriaAustriaStudy Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy
AustriaComparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant
AustriaStudy of olaparib, durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations
AustriaStudy of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer
AustriaStudy Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics
AustriaStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
AustriaStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
AustriaStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
AustriaStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, breast cancer, and lung cancer treatments. Research includes evaluation of novel therapeutic combinations and targeted therapies for various cancer types.
Several trials are investigating innovative approaches for both early-stage and metastatic diseases.
Clinical trials examining new treatments for stroke prevention and cardiac conditions. Research includes studies on novel anticoagulants and preventive therapies.
Focus on reducing major adverse cardiovascular events and improving patient outcomes.
Innovative research in chronic kidney disease, plaque psoriasis, and other specialized conditions. Studies evaluate both new treatments and improved therapeutic approaches.
Trials aim to advance treatment options and improve quality of life for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
